• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Diabetic nephropathy and apolipoprotein E2 allele

Research Project

Project/Area Number 12671128
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionKAWASAKI MEDICAL SCHOOL

Principal Investigator

ETO Masaaki  Kawasaki Medical School,Department of Medicine,Associate professor, 医学部, 助教授 (90133818)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥2,500,000 (Direct Cost: ¥2,500,000)
Fiscal Year 2001: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2000: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordsapolipoprotein E / diabetic nephropathy / remant lipoproteins / mesangial cells / apolipoprotein E2 / トリグリセライド / メサンギウム細胞 / PKC活性 / ヒトメサンギウム細胞 / RLP / 遺伝子
Research Abstract

Previously we demonstrated that the apolipoprotein (apo) E e2 allele is associated with the progression of diabetic nephropathy. The aim of the present study is to further investigate the association between apo E genetic polymorphism, plasma remnant lipoproteins and diabetic nephropathy. One hundred and fifty eight type 2 diabetic patients who had a diabetes duration over 10 years were divided into the 3 apo E groups ; apo E2, E3/3 and E4.Plasma levels of lipids and remnant lipoproteins were measured.The effect of apo E2 triglyceride (TG)-rich lipoproteins including remnant lipoproteins on accumulation of cholesteryl esters by human mesangial cells (HMCs) was estimated by measurement of the stimulation of 14C-oleate incorporation into cholesteryl esters. The frequency of overt nephropathy was significant^ higher in apo E2 diabetic patients (59.1%) than in apo E3/3 (34.3%) or apo E4 patients (8 8%) and the frequency of normoalbuminuria was significantly higher in apo E4 diabetic patients (67 6%) than in apo E3/3 (34.3%) or apo E2 patients (4.5%). Logistical regression analysis showed that odds ratios of apo E2 and apo E4 genotypes for the presence of overt nephropathy were 10.179 (p=00349) and 0.129 (p=0.0028), respectively. Plasma levels of triglyceride and remnant-like lipoprotein particles (RLP)-chol and were significantly higher in apo E2 patients, and significantly lower, n apo E4 patients than in apo E3/3 patients. Apo E2 TG-rich lipoproteins stimulated accumulate of cholesteryl esters by HMCs significantly more than apo E3/3 or apo E4 TG-rich lipoproteins. Apo E2, s a positive genetic factor and apo E4 is a negative genetic factor for diabetic nephropathy. Apo E2 TG-rich lipoproteins were uptaken more avidly by HMCs. Remnant lipoproteins may have an important role in the progression of diabetic nephropathy.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K: "Apolipoprotein E genetic polymorphism, remnant lipoproteins and nephropathy in Type 2 diabetic patients"Am J Kidney Dis. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Saito M, Eto M, Kawasaki F, Kohara K, Yoneda M, Matsuda M, Matsuki M, Kaku K: "Effect of apo E2-remnant lipoproteins on PKC activity and TGF-β and protein matrix synthesis in mesangial cells"Diabetologia. 44(Suppl.1). A264 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Iwashima Y, Abiko A, Ushikubi F, Hata A, Kaku K, Sano H, Eto M: "Downregulation of the voltage-dependent calcium channel (VDCC) β-subunit mRNAs in pancreatic islets of type 2 diabetic rats"Biochem.Biophys.Res.Comm. 290. 923-932 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Saito M, Eto M, Kaku K: "Remnant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apo E2 genotype"Metabolisim. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Eto M, Saito M, Nakata H, Iwashima Y, Watanabe K, Makino I Kaku K: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan"Clinical Genetics. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Iwashima Y, Eto M, Hata A, Kaku K, Horiuchi S, Ushibuki F, Sano: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages"Biochem, Biophys.Res.Comm. 277. 368-380 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Abiko A, Eto M, Makino I, Araki N, Horiuchi S: "Increased levels of advanced glycation end producuts in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay"Metabolism. 567-573 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Eto M, Saito M, Kaku K, et al.: "Apolipoprotein E genetic polymorphism, remanat lipoproteins and nephropathy in type 2 diabetic patients."American J Kidney Diseases. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] SaitoM, EtoM, KakuK.: "Remant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apolipoprotein E2 genotypes"Metabolism. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Eto M, Saito M, Kaku K, et al.: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan."Clinical Genetics. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Iwashima Y, Abiko A, Ushikubi F, Hata A, KakuK, Sano H, EtoM.: "Downregulation of the voltage-dependent calcium channel (VDCC) β-subunit mRNAs in pancreatic islets of type 2 diabetic rats."Biochem. Biophys. Res. Comm.. 280. 923-932 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] IwashimaY, Eto M, HataA, Kaku K, Horiuchi S, Ushibuki F, SanoH: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem. Biophys. Res. Comm.. 277. 368-380 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Abiko A, Eto M, Makino I, Araki N, Hpriuchi S: "Increased levels of advanced glycation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay."Metabolism. 49. 567-573 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Iwashima Y, Abiko A, Ushikubi F, Hata A, Kaku K, Sano H, Eto M: "Downregulation of the voltage-dependent calcium channel (VDCC) β-subunit mRNAs in pancreatic islets of type 2 diabetic rats"Biochem. Biophys. Res. Comm. 290. 923-932 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Saito M, Eto M, Kawasaki F, Kohara K, Yoneda M, Matsuda M, Matsuki M, Kaku K: "Effect of apo E2-remnant lipoproteins on PKC activity and TGF-β and protein matrix synthesis in mesangial cells"Diabetologia. 44(suppl.1). A264 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K: "Apolipoprotein E genetic polymorphism, remnant lipoproteins and nephropathy in Type 2 diabetic patients"Am J Kidney Dis. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Saito M, Eto M, Kaku K: "Remnant-like lipoprotein particles (RLP) in type 2 diabetic patients with apolipoprotein E3/3 genotype and with apo E2 genotype"Metabolisim. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Eto M, Saito M, Nakata H, Iwashima Y, Watanabe K, Makino I, Kaku K: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan"Clinical Genetics. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Eto M,Saito M,Kawasaki F,Takeuchi Y,Matsuda M,Kaku K.: "Apolipoprotein E2 and E4 alleles and diabetic nephropathy"Diabetologia. 43(Suppl.1). A13 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Saito M,Eto M,Kawasaki F,Takeuchi Y,Matsuda M,Kaku K.: "Remant-like particles (RLPs) from type 2 diabetic patients with apolipoprotein E2 enhance cholesteryl ester synthesis in macrophages."Diabetes. 49(Suppl.1). A270 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Iwashima Y,Eto M,Hata A,Kaku K,Horiuchi S,Ushibuki F,Sano H,: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Comm.. 277. 368-380 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Abiko A,Eto M,Makino I,Araki N,Horiuchi S,: "Increased levels of advanced glycation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay."Metabolism. 49. 567-573 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi